A beam of "light" can "double" - from precision machining and precise detection to new chips and autonomous driving, optoelectronic information technology continues to leap, giving birth to a number of new fields and tracks. A pill of "medicine" is starting to "go global" - Since the beginning of this year, more than 30 domestic innovative drugs have been publicly disclosed for authorized "overseas" transactions, with a project amount of about 15 billion US dollars, an increase of more than twice year-on-year. Like the seeds sown, the power of innovation thrives. Technology, as a key variable, is becoming the "maximum increment" of high-quality development. New kinetic energy is accumulating on the land of Sanqin, and "light" is gathering. Being able to carve patterns on hair is laser made; It has lower energy consumption and faster information transmission, making it an optoelectronic chip; In just a few minutes, tiny traces of pesticides or bacteria were discovered, which are photon sensing... Shaanxi Optoelectronics Pioneer Institute, located in Xi'an High tech Zone, has incubated more than 50 technology enterprises related to "light", and many of them have a market share of over 50% in segmented fields. Looking at the entire Shaanxi province, there are over 300 high-tech enterprises in the upstream and downstream of the photon industry chain, with an annual output value exceeding 30 billion yuan. The source lies in the transformation of core technological achievements, and the industry thrives due to innovation. After being founded in the United States for three years, Safran Semiconductor, which holds a patent, moved to Xi'an. Founder Chen Chen told reporters that without the large-scale advanced equipment provided by Shaanxi Optoelectronics Pioneer Institute, the company could not quickly mass produce the new generation display technology products. "It is the direction we have been working hard to transform the 'potential energy' of scientific research resources into the 'kinetic energy' of industrial development over the years." Mi Lei, a researcher of Xi'an Institute of Optics and Mechanics, Chinese Academy of Sciences, and the executive director of Shaanxi Optoelectronics Pioneer Institute, said that the transformation chain of samples, products, and commodities should be opened up more quickly. By practicing internal skills well and continuously upgrading competitiveness, enterprises become stronger through innovation. In August of this year, Xinda Biotechnology approved the launch of its independently developed Toracizumab Injection, which took 8 years. This is the first domestically produced and the third globally produced PCSK9 monoclonal antibody drug, commonly known as the "lipid-lowering needle". At the beginning of his entrepreneurship, Yu Dechao, the chairman of Xinda Biotechnology, borrowed a room from Suzhou Industrial Park, which was so small that it couldn't even accommodate a refrigerator for storing reagents. But his confidence is firm: to make innovative drugs that meet international standards! Over the past 12 years, a total of 15 billion yuan has been invested in research and development, and 10 innovative drugs have been launched; The first commercialized product, Daboshu, is the only PD-1 drug approved for first-line treatment of the top five high incidence tumors in China, which can be reimbursed by the national medical insurance... In the first half of this year, Xinda Biotech's revenue exceeded 2.7 billion yuan, a year-on-year increase of 20.6%; The product revenue in the third quarter exceeded 1.6 billion yuan, a year-on-year increase of over 45%. The ability for independent innovation is like gold, it will shine sooner or later. Towards the end of the year, reporters visited the front lines of China's economic development and felt the "acceleration" of cultivating new driving forces in various regions - Guangdong. In the first half of this year, the added value of advanced manufacturing increased by 3.3%; From January to October, investment in industrial technology transformation increased by 22.3% year-on-year, the highest growth rate in five years. Shanghai plans to build about 60 characteristic industrial parks by 2026, gathering about 5500 high-tech enterprises and specialized, refined, and new small and medium-sized enterprises. The total output value of industrial enterprises above designated size will exceed 10000 yuan